Education
About Us
Working with TipRanks
Follow Us
Joseph Cappello Insider Profile
11 Followers
Joseph Cappello, VP, Pharmaceutical Development at Genelux Corp., holds 52.27K shares in Genelux Corp. (Ticker: GNLX). Most recently, Joseph Cappello Sold $4,737 shares of Genelux Corp. on May 13, 2025 for an estimated value of 13.83K.
Joseph Cappello Genelux Corp. (GNLX)VP, Pharmaceutical Development
Genelux Corp. (GNLX)
VP, Pharmaceutical Development
Ranked #44,954 out of 102,674 Corporate Insiders
Profitable Transactions
1 out of 3 Profitable Transactions
Average Return
+3.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Joseph Cappello's holdings
Insider Roles
VP, Pharmaceutical Development
Roles that Joseph Cappello holds in companies
Most Profitable Insider Trade
The most profitable trade made by Joseph Cappello
Joseph Cappello's Trading History
List of latest transactions for each holding click on a transaction to see Joseph Cappello's performance on stock
You May Also Like
Joseph Cappello insider profile FAQ
What is the percentage of profitable transactions made by Joseph Cappello?
The percentage of profitable transactions made by Joseph Cappello is 33%.
What is the average return per transaction made by Joseph Cappello?
The average return per transaction made by Joseph Cappello is 3.60%.
What stocks does Joseph Cappello hold?
Joseph Cappello holds: GNLX stocks.
What was Joseph Cappello’s latest transaction?
Joseph Cappello latest transaction was an Informative Sell of $13.83K.
What was Joseph Cappello's most profitable transaction?
Joseph Cappello’s most profitable transaction was an Informative Sell of GNLX stock on August 22, 2023. The return on the trade was 91.20%.
What is Joseph Cappello's role in Genelux Corp.?
Joseph Cappello's role in Genelux Corp. is VP, Pharmaceutical Development.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.